Patent · US Active

Reduced size self-delivering RNAi compounds

US9080171B2 · kind B2 · utility

53Cited by

172References

15Claims

0Family size

Assignee

RXi Pharmaceuticals Corporation · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
James Cardia · Franklin, US

Key dates

Filing date	Mar 24, 2011
Grant date	Jul 14, 2015
Priority date	—
Expiry date	Jun 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/51
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to methods for in vivo administration of sd-rxRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.